EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Keqiang Ye: The C/EBPb/AEP pathway is the key driver for Alzheimer's disease (AD) and Parkinson's disease (PD) pathogenesis and its specific inhibitor attenuates AD/PD pathologies

Keqiang Ye

Brain Medicine · 2024

DOI: 10.61373/bm024k.0010 ↗

At a glance

Journal article in Brain Medicine, 2024. Written by Keqiang Ye. Cited 1 times so far (Crossref). The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Dr. Keqiang Ye is currently an endowed professor and Department of Biology Chairman at Shenzhen Institute of Advanced Technology (SIAT), China. Prior to this role, he held positions at Emory University in Atlanta, Georgia, USA, serving as an Assistant Professor (2001–2007), a tenured Associate Professor (2007–2010), and a Full Professor (2010–2021). He has received numerous professional honors, notably the Distinguished Scientist Award from the Sontag Foundation (2003) and the American Cancer Research Scholar Award (2004). His research focuses on neurodegenerative diseases, including molecular mechanisms in pathogenesis, early diagnosis, and drug development. With 265 published papers, including contributions to esteemed journals such as Cell , Nature , Nature Medicine , Neuron , and PNAS , among others, Dr. Ye has made significant strides in identifying novel compounds with therapeutic potential for treating neurological diseases, particularly Alzheimer's disease (AD). His work has led to the licensing of these drugs by pharmaceutical companies and their ongoing clinical development. Dr. Ye shares with our readers the highlights of his professional and personal journeys.

Cite

APA

Ye, K. (2024). Keqiang Ye: The C/EBPb/AEP pathway is the key driver for Alzheimer's disease (AD) and Parkinson's disease (PD) pathogenesis and its specific inhibitor attenuates AD/PD pathologies. Brain Medicine. https://doi.org/10.61373/bm024k.0010

Vancouver

Ye K. Keqiang Ye: The C/EBPb/AEP pathway is the key driver for Alzheimer's disease (AD) and Parkinson's disease (PD) pathogenesis and its specific inhibitor attenuates AD/PD pathologies. Brain Medicine. 2024. doi:10.61373/bm024k.0010

BibTeX
@article{Ye2024,
  author = {Ye, Keqiang},
  title = {Keqiang Ye: The C/EBPb/AEP pathway is the key driver for Alzheimer's disease (AD) and Parkinson's disease (PD) pathogenesis and its specific inhibitor attenuates AD/PD pathologies},
  journal = {Brain Medicine},
  year = {2024},
  doi = {10.61373/bm024k.0010}
}
Start for free →